Concepts (281)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 35 | 2024 | 257 | 15.500 |
Why?
|
| Asthma | 46 | 2024 | 976 | 12.670 |
Why?
|
| Nebulizers and Vaporizers | 20 | 2024 | 56 | 7.080 |
Why?
|
| Health Literacy | 12 | 2022 | 72 | 6.080 |
Why?
|
| Patient Readmission | 13 | 2024 | 351 | 5.840 |
Why?
|
| Patient Education as Topic | 16 | 2020 | 359 | 4.830 |
Why?
|
| Metered Dose Inhalers | 13 | 2022 | 33 | 4.520 |
Why?
|
| Hospitalization | 21 | 2024 | 876 | 4.330 |
Why?
|
| Inpatients | 16 | 2024 | 310 | 4.020 |
Why?
|
| Anti-Asthmatic Agents | 9 | 2022 | 75 | 3.290 |
Why?
|
| Patient Care Bundles | 5 | 2023 | 20 | 2.840 |
Why?
|
| Administration, Inhalation | 18 | 2024 | 190 | 2.440 |
Why?
|
| School Health Services | 5 | 2019 | 16 | 1.810 |
Why?
|
| Humans | 116 | 2024 | 89063 | 1.790 |
Why?
|
| Inhalation Spacers | 2 | 2021 | 2 | 1.520 |
Why?
|
| Surveys and Questionnaires | 13 | 2024 | 2612 | 1.480 |
Why?
|
| Quality of Health Care | 5 | 2024 | 385 | 1.230 |
Why?
|
| Child | 25 | 2023 | 7149 | 1.230 |
Why?
|
| Patient Discharge | 4 | 2023 | 320 | 1.100 |
Why?
|
| Parents | 5 | 2020 | 285 | 1.070 |
Why?
|
| Equipment Failure | 2 | 2020 | 121 | 1.050 |
Why?
|
| Telemedicine | 5 | 2024 | 185 | 1.030 |
Why?
|
| Vision, Low | 2 | 2015 | 15 | 1.030 |
Why?
|
| Child, Hospitalized | 2 | 2023 | 34 | 1.020 |
Why?
|
| Female | 53 | 2024 | 46011 | 1.020 |
Why?
|
| Male | 50 | 2024 | 42251 | 0.980 |
Why?
|
| United States | 21 | 2024 | 6955 | 0.970 |
Why?
|
| Vision Disorders | 2 | 2016 | 75 | 0.950 |
Why?
|
| Health Status Disparities | 2 | 2017 | 187 | 0.940 |
Why?
|
| Minority Groups | 5 | 2019 | 144 | 0.940 |
Why?
|
| Hospitals | 4 | 2023 | 299 | 0.900 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2021 | 125 | 0.890 |
Why?
|
| Community Health Workers | 2 | 2022 | 33 | 0.860 |
Why?
|
| Patients | 3 | 2020 | 102 | 0.850 |
Why?
|
| Educational Measurement | 2 | 2016 | 231 | 0.840 |
Why?
|
| Cross-Sectional Studies | 10 | 2023 | 1706 | 0.840 |
Why?
|
| Nonprescription Drugs | 1 | 2022 | 16 | 0.830 |
Why?
|
| Length of Stay | 4 | 2024 | 732 | 0.810 |
Why?
|
| Quality Improvement | 4 | 2020 | 447 | 0.800 |
Why?
|
| Mass Screening | 3 | 2017 | 636 | 0.790 |
Why?
|
| Patient Participation | 3 | 2024 | 224 | 0.770 |
Why?
|
| Quality of Life | 5 | 2022 | 1662 | 0.750 |
Why?
|
| Women | 1 | 2021 | 25 | 0.740 |
Why?
|
| Adult | 22 | 2024 | 26507 | 0.740 |
Why?
|
| Awards and Prizes | 1 | 2021 | 37 | 0.730 |
Why?
|
| Physician-Patient Relations | 6 | 2016 | 625 | 0.730 |
Why?
|
| Drug Misuse | 1 | 2020 | 2 | 0.730 |
Why?
|
| Research Support as Topic | 1 | 2021 | 85 | 0.720 |
Why?
|
| Medical Overuse | 1 | 2020 | 36 | 0.720 |
Why?
|
| Research Personnel | 1 | 2021 | 71 | 0.720 |
Why?
|
| Attitude of Health Personnel | 2 | 2016 | 643 | 0.720 |
Why?
|
| Emergency Service, Hospital | 6 | 2023 | 521 | 0.710 |
Why?
|
| Deductibles and Coinsurance | 1 | 2020 | 7 | 0.700 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2023 | 1176 | 0.700 |
Why?
|
| Chicago | 11 | 2024 | 1423 | 0.690 |
Why?
|
| Practice Guidelines as Topic | 5 | 2019 | 1043 | 0.690 |
Why?
|
| Middle Aged | 24 | 2024 | 25863 | 0.680 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2020 | 531 | 0.670 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2022 | 216 | 0.670 |
Why?
|
| Disease Management | 3 | 2020 | 329 | 0.660 |
Why?
|
| Severity of Illness Index | 4 | 2024 | 1837 | 0.660 |
Why?
|
| Natural Language Processing | 1 | 2019 | 36 | 0.650 |
Why?
|
| Continuity of Patient Care | 1 | 2020 | 172 | 0.640 |
Why?
|
| Adolescent | 11 | 2024 | 9237 | 0.610 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 705 | 0.600 |
Why?
|
| Students, Medical | 4 | 2024 | 418 | 0.600 |
Why?
|
| Education, Medical, Undergraduate | 3 | 2024 | 178 | 0.600 |
Why?
|
| Schools | 2 | 2018 | 75 | 0.600 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 738 | 0.590 |
Why?
|
| Social Media | 1 | 2019 | 93 | 0.580 |
Why?
|
| Attitude to Health | 1 | 2018 | 222 | 0.570 |
Why?
|
| Betacoronavirus | 1 | 2020 | 261 | 0.570 |
Why?
|
| Risk Factors | 7 | 2022 | 5466 | 0.560 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2017 | 72 | 0.560 |
Why?
|
| Respiratory System Agents | 1 | 2016 | 7 | 0.550 |
Why?
|
| Accidental Falls | 1 | 2016 | 51 | 0.540 |
Why?
|
| Health Policy | 5 | 2018 | 184 | 0.540 |
Why?
|
| Delirium | 2 | 2016 | 72 | 0.530 |
Why?
|
| Point-of-Care Testing | 1 | 2015 | 25 | 0.530 |
Why?
|
| Healthcare Disparities | 2 | 2018 | 410 | 0.520 |
Why?
|
| Psychometrics | 2 | 2023 | 329 | 0.520 |
Why?
|
| Spirometry | 4 | 2023 | 68 | 0.520 |
Why?
|
| Data Collection | 3 | 2013 | 375 | 0.510 |
Why?
|
| Patient Care Team | 2 | 2018 | 283 | 0.510 |
Why?
|
| Disease Progression | 1 | 2020 | 1488 | 0.510 |
Why?
|
| Eyeglasses | 1 | 2015 | 8 | 0.510 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 319 | 0.500 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 304 | 0.490 |
Why?
|
| Patient Advocacy | 1 | 2015 | 52 | 0.490 |
Why?
|
| Pediatrics | 1 | 2019 | 352 | 0.490 |
Why?
|
| Medicare | 3 | 2024 | 423 | 0.480 |
Why?
|
| HIV Infections | 1 | 2023 | 835 | 0.470 |
Why?
|
| Prospective Studies | 11 | 2024 | 4273 | 0.470 |
Why?
|
| Trust | 2 | 2016 | 98 | 0.460 |
Why?
|
| Heart Failure | 1 | 2023 | 1180 | 0.450 |
Why?
|
| Guideline Adherence | 4 | 2024 | 229 | 0.450 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 63 | 0.440 |
Why?
|
| Aged | 14 | 2024 | 19077 | 0.440 |
Why?
|
| Logistic Models | 3 | 2022 | 1212 | 0.430 |
Why?
|
| Hospital Medicine | 2 | 2023 | 23 | 0.430 |
Why?
|
| Medical Staff, Hospital | 1 | 2013 | 108 | 0.430 |
Why?
|
| Internship and Residency | 4 | 2012 | 1041 | 0.420 |
Why?
|
| Retrospective Studies | 7 | 2024 | 9003 | 0.420 |
Why?
|
| Biomedical Research | 3 | 2024 | 398 | 0.420 |
Why?
|
| Family | 1 | 2013 | 325 | 0.390 |
Why?
|
| Physicians | 3 | 2020 | 689 | 0.390 |
Why?
|
| Urban Population | 4 | 2018 | 224 | 0.390 |
Why?
|
| Patient Satisfaction | 2 | 2016 | 461 | 0.380 |
Why?
|
| Cognition | 1 | 2015 | 580 | 0.380 |
Why?
|
| Schools, Medical | 4 | 2024 | 134 | 0.370 |
Why?
|
| Child, Preschool | 6 | 2023 | 3717 | 0.370 |
Why?
|
| Aging | 1 | 2015 | 716 | 0.370 |
Why?
|
| Minority Health | 1 | 2010 | 10 | 0.370 |
Why?
|
| Societies, Medical | 3 | 2024 | 570 | 0.350 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2024 | 53 | 0.350 |
Why?
|
| Cost Savings | 2 | 2022 | 69 | 0.350 |
Why?
|
| Self Administration | 3 | 2018 | 72 | 0.340 |
Why?
|
| Chronic Disease | 3 | 2023 | 948 | 0.340 |
Why?
|
| Feasibility Studies | 4 | 2020 | 779 | 0.340 |
Why?
|
| Self Care | 4 | 2016 | 164 | 0.340 |
Why?
|
| Poverty | 3 | 2019 | 180 | 0.330 |
Why?
|
| Teaching | 1 | 2010 | 147 | 0.320 |
Why?
|
| Patient Outcome Assessment | 3 | 2017 | 84 | 0.310 |
Why?
|
| Educational Status | 2 | 2023 | 194 | 0.310 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2019 | 266 | 0.300 |
Why?
|
| Comorbidity | 2 | 2024 | 948 | 0.300 |
Why?
|
| Comparative Effectiveness Research | 2 | 2020 | 53 | 0.300 |
Why?
|
| Equipment Design | 2 | 2021 | 415 | 0.290 |
Why?
|
| Students | 2 | 2018 | 169 | 0.280 |
Why?
|
| Self Concept | 2 | 2019 | 132 | 0.280 |
Why?
|
| Internet | 2 | 2020 | 318 | 0.280 |
Why?
|
| Socioeconomic Factors | 3 | 2018 | 582 | 0.280 |
Why?
|
| Health Services Accessibility | 3 | 2020 | 424 | 0.260 |
Why?
|
| Curriculum | 2 | 2024 | 567 | 0.260 |
Why?
|
| Communication Barriers | 2 | 2015 | 29 | 0.260 |
Why?
|
| Qualitative Research | 2 | 2018 | 291 | 0.250 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 833 | 0.250 |
Why?
|
| Program Evaluation | 2 | 2020 | 306 | 0.250 |
Why?
|
| Cost Sharing | 1 | 2024 | 17 | 0.240 |
Why?
|
| Electronic Health Records | 3 | 2017 | 341 | 0.240 |
Why?
|
| Checklist | 2 | 2016 | 61 | 0.240 |
Why?
|
| Delphi Technique | 1 | 2024 | 92 | 0.240 |
Why?
|
| Control Groups | 1 | 2023 | 15 | 0.220 |
Why?
|
| Diagnosis-Related Groups | 1 | 2023 | 21 | 0.220 |
Why?
|
| Dry Powder Inhalers | 2 | 2020 | 3 | 0.220 |
Why?
|
| Sex Distribution | 2 | 2021 | 171 | 0.210 |
Why?
|
| Medication Adherence | 1 | 2024 | 138 | 0.210 |
Why?
|
| Health Equity | 1 | 2024 | 94 | 0.200 |
Why?
|
| Health Expenditures | 2 | 2024 | 91 | 0.200 |
Why?
|
| Polysomnography | 1 | 2022 | 151 | 0.200 |
Why?
|
| Costs and Cost Analysis | 2 | 2020 | 153 | 0.200 |
Why?
|
| Young Adult | 4 | 2024 | 6288 | 0.200 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2021 | 35 | 0.200 |
Why?
|
| Aftercare | 1 | 2022 | 87 | 0.190 |
Why?
|
| Syndrome | 1 | 2022 | 449 | 0.190 |
Why?
|
| Exercise Therapy | 1 | 2021 | 81 | 0.190 |
Why?
|
| Cross Infection | 2 | 2013 | 146 | 0.190 |
Why?
|
| Time Factors | 3 | 2020 | 5320 | 0.190 |
Why?
|
| Feedback | 1 | 2021 | 134 | 0.190 |
Why?
|
| Insurance, Health | 2 | 2020 | 159 | 0.190 |
Why?
|
| Physician's Role | 2 | 2013 | 177 | 0.190 |
Why?
|
| Focus Groups | 2 | 2018 | 170 | 0.190 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 3657 | 0.180 |
Why?
|
| Needs Assessment | 2 | 2018 | 157 | 0.180 |
Why?
|
| Machine Learning | 1 | 2022 | 257 | 0.180 |
Why?
|
| Prevalence | 3 | 2024 | 1240 | 0.180 |
Why?
|
| School Nursing | 1 | 2019 | 3 | 0.170 |
Why?
|
| Forced Expiratory Volume | 1 | 2020 | 124 | 0.170 |
Why?
|
| Self-Management | 2 | 2017 | 39 | 0.170 |
Why?
|
| Primary Health Care | 2 | 2020 | 351 | 0.170 |
Why?
|
| Health Promotion | 1 | 2021 | 163 | 0.170 |
Why?
|
| Mentors | 2 | 2023 | 85 | 0.170 |
Why?
|
| Desensitization, Immunologic | 1 | 2019 | 37 | 0.160 |
Why?
|
| Prescription Fees | 1 | 2018 | 10 | 0.160 |
Why?
|
| Cause of Death | 1 | 2020 | 266 | 0.160 |
Why?
|
| Formoterol Fumarate | 1 | 2018 | 8 | 0.160 |
Why?
|
| Patient Rights | 1 | 2018 | 16 | 0.160 |
Why?
|
| Nurses | 1 | 2018 | 40 | 0.160 |
Why?
|
| Respiration Disorders | 1 | 2018 | 41 | 0.160 |
Why?
|
| Disabled Children | 1 | 2018 | 44 | 0.160 |
Why?
|
| Congresses as Topic | 1 | 2019 | 112 | 0.150 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 988 | 0.150 |
Why?
|
| Counseling | 2 | 2010 | 163 | 0.150 |
Why?
|
| Allergens | 1 | 2019 | 183 | 0.150 |
Why?
|
| Awareness | 1 | 2018 | 89 | 0.150 |
Why?
|
| Health Education | 1 | 2018 | 105 | 0.150 |
Why?
|
| Risk Assessment | 4 | 2021 | 2290 | 0.150 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2017 | 12 | 0.150 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2017 | 257 | 0.150 |
Why?
|
| Videoconferencing | 1 | 2017 | 15 | 0.150 |
Why?
|
| Lung | 2 | 2022 | 1258 | 0.150 |
Why?
|
| Inhalation | 1 | 2017 | 31 | 0.150 |
Why?
|
| Aged, 80 and over | 4 | 2024 | 6777 | 0.150 |
Why?
|
| Community Participation | 1 | 2017 | 38 | 0.140 |
Why?
|
| Language | 2 | 2015 | 154 | 0.140 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 2752 | 0.140 |
Why?
|
| Videotape Recording | 1 | 2017 | 48 | 0.140 |
Why?
|
| Microcomputers | 1 | 2016 | 26 | 0.140 |
Why?
|
| Patient-Centered Care | 1 | 2019 | 207 | 0.140 |
Why?
|
| Mental Status Schedule | 1 | 2016 | 25 | 0.130 |
Why?
|
| Survival Analysis | 1 | 2020 | 1533 | 0.130 |
Why?
|
| Bronchodilator Agents | 3 | 2024 | 66 | 0.130 |
Why?
|
| Reimbursement Mechanisms | 1 | 2016 | 41 | 0.130 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 89 | 0.130 |
Why?
|
| Sleep | 2 | 2023 | 452 | 0.130 |
Why?
|
| Medicaid | 1 | 2019 | 229 | 0.130 |
Why?
|
| Internal Medicine | 2 | 2010 | 355 | 0.130 |
Why?
|
| Multilingualism | 1 | 2015 | 10 | 0.130 |
Why?
|
| Face | 1 | 2016 | 116 | 0.130 |
Why?
|
| Advisory Committees | 1 | 2016 | 88 | 0.130 |
Why?
|
| Motivation | 1 | 2018 | 296 | 0.130 |
Why?
|
| Patient Transfer | 1 | 2016 | 94 | 0.130 |
Why?
|
| Problem Solving | 1 | 2015 | 54 | 0.130 |
Why?
|
| Acetates | 1 | 2015 | 65 | 0.130 |
Why?
|
| Respiratory Sounds | 1 | 2015 | 34 | 0.130 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2016 | 58 | 0.130 |
Why?
|
| Translating | 1 | 2015 | 18 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1591 | 0.130 |
Why?
|
| Cohort Studies | 2 | 2024 | 2863 | 0.130 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1067 | 0.130 |
Why?
|
| Vision Tests | 1 | 2015 | 20 | 0.130 |
Why?
|
| Androstadienes | 1 | 2015 | 72 | 0.130 |
Why?
|
| Quinolines | 1 | 2015 | 91 | 0.120 |
Why?
|
| Linear Models | 1 | 2016 | 421 | 0.120 |
Why?
|
| Memory Disorders | 1 | 2015 | 68 | 0.120 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 433 | 0.120 |
Why?
|
| Acute Disease | 1 | 2017 | 841 | 0.120 |
Why?
|
| Mobile Applications | 1 | 2016 | 68 | 0.120 |
Why?
|
| Registries | 1 | 2019 | 778 | 0.120 |
Why?
|
| Sex Factors | 1 | 2017 | 1063 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 771 | 0.120 |
Why?
|
| Patient Selection | 1 | 2017 | 682 | 0.110 |
Why?
|
| Research Design | 1 | 2017 | 597 | 0.110 |
Why?
|
| Memory | 1 | 2015 | 220 | 0.110 |
Why?
|
| Software | 1 | 2017 | 665 | 0.110 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 345 | 0.110 |
Why?
|
| Communication | 1 | 2016 | 457 | 0.100 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 1149 | 0.100 |
Why?
|
| Cooperative Behavior | 2 | 2023 | 179 | 0.080 |
Why?
|
| Documentation | 2 | 2020 | 103 | 0.070 |
Why?
|
| Caregivers | 2 | 2017 | 159 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2020 | 8203 | 0.060 |
Why?
|
| Medication Therapy Management | 1 | 2024 | 16 | 0.060 |
Why?
|
| Medicare Part C | 1 | 2024 | 7 | 0.060 |
Why?
|
| Problem-Based Learning | 1 | 2024 | 32 | 0.060 |
Why?
|
| Actigraphy | 1 | 2024 | 59 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2017 | 865 | 0.060 |
Why?
|
| Staff Development | 1 | 2023 | 26 | 0.060 |
Why?
|
| Quality Indicators, Health Care | 2 | 2016 | 146 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2023 | 185 | 0.050 |
Why?
|
| Canada | 1 | 2021 | 208 | 0.050 |
Why?
|
| Sodium | 1 | 2021 | 331 | 0.050 |
Why?
|
| Efficiency | 1 | 2020 | 40 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2021 | 348 | 0.040 |
Why?
|
| Glucose | 1 | 2021 | 630 | 0.040 |
Why?
|
| Child Welfare | 1 | 2018 | 38 | 0.040 |
Why?
|
| Health Information Exchange | 1 | 2017 | 12 | 0.040 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 192 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 47 | 0.030 |
Why?
|
| Confidentiality | 1 | 2016 | 77 | 0.030 |
Why?
|
| Observer Variation | 1 | 2017 | 610 | 0.030 |
Why?
|
| Allergy and Immunology | 1 | 2015 | 13 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2015 | 145 | 0.030 |
Why?
|
| Cultural Diversity | 1 | 2015 | 57 | 0.030 |
Why?
|
| Program Development | 1 | 2015 | 123 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2015 | 334 | 0.030 |
Why?
|
| Mental Recall | 1 | 2016 | 157 | 0.030 |
Why?
|
| Illinois | 1 | 2015 | 472 | 0.030 |
Why?
|
| Pneumococcal Vaccines | 1 | 2013 | 28 | 0.030 |
Why?
|
| Catheter-Related Infections | 1 | 2013 | 23 | 0.030 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2012 | 19 | 0.030 |
Why?
|
| Pressure Ulcer | 1 | 2013 | 42 | 0.030 |
Why?
|
| Sick Leave | 1 | 2012 | 13 | 0.030 |
Why?
|
| Workplace | 1 | 2012 | 29 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2015 | 341 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2015 | 395 | 0.020 |
Why?
|
| Attention | 1 | 2016 | 394 | 0.020 |
Why?
|
| Phenotype | 1 | 2017 | 2439 | 0.020 |
Why?
|
| Venous Thrombosis | 1 | 2013 | 250 | 0.020 |
Why?
|
| Incidence | 1 | 2012 | 1592 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2009 | 327 | 0.020 |
Why?
|